Francesca Palese

Francesca Palese

Auto-generated profile, based on publicly available information

Francesca Palese

Institut Pasteur, Université Paris Cité, CNRS UMR 3691, Membrane Traffic and Pathogenesis, F-75015 Paris, France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
NRNatalia Realini
Natalia Realini
FPFrancesca Palese
Francesca Palese
DPDaniela Pizzirani
Daniela Pizzirani
SPSilvia Pontis
Silvia Pontis
ABAbdul Basit
Abdul Basit
DPDaniele Piomelli
Daniele Piomelli
Acid ceramidase (AC) is a lysosomal cysteine amidase that controls sphingolipid signaling by lowering the levels of ceramides and concomitantly increasing those of sphingosine and its bioactive metabolite, sphingosine 1-phosphate. In the present study, we evaluated the role of AC-regulated sphingolipid signaling in melanoma. We found that AC expression is markedly elevated in normal human melanocytes and proliferative melanoma cell lines, compared with other skin cells (keratinocytes and fibroblasts) and non-melanoma cancer cells. High AC expression was also observed in biopsies from human subjects with Stage II melanoma. Immunofluorescence studies revealed that the subcellular localization of AC differs between melanocytes (where it is found in both cytosol and nucleus) and melanoma cells (where it is primarily localized to cytosol). In addition to having high AC levels, melanoma cells generate lower amounts of ceramides than normal melanocytes do. This down-regulation in ceramide production appears to result from suppression of the de novo biosynthesis pathway. To test whether AC might contribute to melanoma cell proliferation, we blocked AC activity using a new potent (IC50 = 12 nm) and stable inhibitor. AC inhibition increased cellular ceramide levels, decreased sphingosine 1-phosphate levels, and acted synergistically with several, albeit not all, antitumoral agents. The results suggest that AC-controlled sphingolipid metabolism may play an important role in the control of melanoma proliferation.

1 February 2020 in Neurobiology of Aging
Verified
Journal Article
Closed access
FPFrancesca Palese
Francesca Palese
EBElisa Bonomi
Elisa Bonomi
TNTommaso Nuzzo
Tommaso Nuzzo
ABAlberto Benussi
Alberto Benussi
MMManuela Mellone
Manuela Mellone
FGFabrizio Gardoni
Fabrizio Gardoni

6 May 2020 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
DIDevon Ivy
Devon Ivy
FPFrancesca Palese
Francesca Palese
VVValentina Vozella
Valentina Vozella
YFYannick Fotio
Yannick Fotio
AYAylin Yalcin
Aylin Yalcin
DPDaniele Piomelli
Daniele Piomelli

22 October 2021 in Science Advances
Verified
Journal Article
Open access
YFYannick Fotio
Yannick Fotio
Kwang Mook JungKwang Mook Jung
Kwang Mook Jung
FPFrancesca Palese
Francesca Palese
RORenate Obenaus
Renate Obenaus
ATAlex Mabou Tagne
Alex Mabou Tagne
DPDaniele Piomelli
Daniele Piomelli
The enzyme NAAA is a critical control node that offers a druggable target to prevent the transition from acute to chronic pain.

1 July 2025 in Physiological Reviews
Verified
Journal Article
Closed access
FPFrancesca Palese
Francesca Palese
MRMalalaniaina Rakotobe
Malalaniaina Rakotobe
CZChiara Zurzolo
Chiara Zurzolo
Tunneling nanotubes (TNTs) are thin tubular membrane protrusions that connect distant cells, generating a complex cellular network. Over the past few decades, research on TNTs has provided important insights into their biology, including structural composition, formation mechanisms, modulators, and functionality. It has been discovered that TNTs allow cytoplasmic continuity between connected cells, facilitating fast intercellular communication via both passive and active exchange of materials. These features are pivotal in the nervous system, where rapid processing of inputs is physiologically required. TNTs have been implicated in the progression of neurodegenerative diseases and cancer in various in vitro models, and TNT-like structures have also been observed in the developing brain and in vivo. This highlights their significant role in pathophysiological processes. In this comprehensive review we aim to provide an extensive overview of TNTs, starting from key structural features and mechanisms of formation and describing the main experimental techniques used to detect these structures both in vitro and in vivo. We focus primarily on the nervous system, where the discovery of TNTs could prompt a reconsideration of the brain functioning as individual units (the neuronal theory of Cajal) versus neurons being physically connected, as Golgi believed. We illustrate the involvement of TNTs in brain development and neurodegenerative states and highlight the limitations and future research needs in this field.

4 November 2019 in Scientific Reports
Verified
Journal Article
Open access
FPFrancesca Palese
Francesca Palese
SPSilvia Pontis
Silvia Pontis
NRNatalia Realini
Natalia Realini
DPDaniele Piomelli
Daniele Piomelli
N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) catalyzes the cleavage of membrane NAPEs into bioactive fatty-acid ethanolamides (FAEs). Along with this precursor role, NAPEs might also serve autonomous signaling functions. Here, we report that injections of 6-hydroxydopamine (6-OHDA) into the mouse striatum cause a local increase in NAPE and FAE levels, which precedes neuronal cell death. NAPE, but not FAE, accumulation is enhanced in mice lacking NAPE-PLD, which display a substantial reduction in 6-OHDA-induced neurotoxicity, as shown by increased survival of substantia nigra dopamine neurons, integrity of striatal dopaminergic fibers, and striatal dopamine metabolite content. Reduced damage is accompanied by attenuation of the motor response evoked by apomorphine. Furthermore, NAPE-PLD silencing protects cathecolamine-producing SH-SY5Y cells from 6-OHDA-induced reactive oxygen species formation, caspase-3 activation and death. Mechanistic studies in mice suggest the existence of multiple molecular contributors to the neuroprotective effects of NAPE-PLD deletion, including suppression of Rac1 activity and attenuated transcription of several genes (Cadps, Casp9, Egln1, Kcnj6, Spen, and Uchl1) implicated in dopamine neuron survival and/or Parkinson’s disease. The findings point to a previously unrecognized role for NAPE-PLD in the regulation of dopamine neuron function, which may be linked to the control of NAPE homeostasis in membranes.